Compare AIRE & POM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AIRE | POM |
|---|---|---|
| Founded | 2021 | 2015 |
| Country | United States | China |
| Employees | 54 | N/A |
| Industry | | Other Specialty Stores |
| Sector | | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.3M | 13.5M |
| IPO Year | 2023 | N/A |
| Metric | AIRE | POM |
|---|---|---|
| Price | $2.12 | $0.10 |
| Analyst Decision | Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $1.30 | N/A |
| AVG Volume (30 Days) | 151.8K | ★ 18.2M |
| Earning Date | 04-28-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 60.34 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $4,518,498.00 | N/A |
| Revenue This Year | $129.06 | N/A |
| Revenue Next Year | $83.72 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 376.42 | N/A |
| 52 Week Low | $0.14 | $0.06 |
| 52 Week High | $3.98 | $6.43 |
| Indicator | AIRE | POM |
|---|---|---|
| Relative Strength Index (RSI) | 51.49 | 35.96 |
| Support Level | $0.31 | $0.10 |
| Resistance Level | $3.98 | $0.44 |
| Average True Range (ATR) | 0.24 | 0.01 |
| MACD | -0.08 | 0.00 |
| Stochastic Oscillator | 27.84 | 4.61 |
ReAlpha Tech Corp is a real estate technology company. The group is engaged in an end-to-end commission-free homebuying platform. It develops and utilizes its artificial intelligence-focused technology stack to empower retail investor participation in short-term rental properties, which are real estate units listed for a rental term. It provides short-term rental investment opportunities to everyday investors. The company has developed technologies and tools that allow for the analysis of short-term rental properties using AI to provide insight into that property's potential profitability and ways to increase such profitability. The company's reportable segments are Homebuying Services and the Technology Services segment.
Pomdoctor Ltd is an online medical services platform for chronic diseases in China. With a focus on chronic disease management and pharmaceutical services, its business model forms a one-stop platform for medical services, which organically connects patients to doctors and pharmaceutical products. Its experience in tackling chronic diseases can be traced back to the launch of its platform on mobile devices. The company operates in two segments: Internet hospital, and Pharmaceutical supply chain. The majority of revenue is derived from the Pharmaceutical supply chain segment.